Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer
Author:
Affiliation:
1. Hematology-Oncology Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts
2. Analysis Group, Inc., Boston, Massachusetts
3. Novartis Pharmaceuticals Corp., East Hanover, New Jersey
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference15 articles.
1. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997
2. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer;Messing;N Engl J Med,1999
3. Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens;Eriksson;Calcif Tissue Int,1995
4. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma longitudinal evaluation and response to intermittent cyclic etidronate therapy;Diamond;Cancer,1998
5. Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma;Maillefert;J Urol,1999
Cited by 178 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hormoontherapie voor prostaatkanker: gevolgen voor de botgezondheid;Tijdschrift voor Urologie;2024-02-28
2. Testosterone Treatment and Fractures in Men with Hypogonadism;New England Journal of Medicine;2024-01-18
3. Validation of JSBMR’s CTIBL manual for Japanese men receiving androgen deprivation therapy for prostate cancer;Journal of Bone and Mineral Metabolism;2023-07-27
4. Quantitative ultrasound of the calcaneus (QUS): A valuable tool in the identification of patients with non-metastatic prostate cancer requiring screening for osteoporosis;Bone Reports;2023-06
5. Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries;European Urology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3